We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $24.3B
1-Year Est. Return 34.41%
This Fund
S&P 500
This Quarter Est. Return
-2.58%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$14.9B
AUM Growth
-$125M
Cap. Flow
+$602M
Cap. Flow %
4.04%
Top 10 Hldgs %
16.63%
Holding
1,195
New
6
Increased
170
Reduced
89
Closed
18

Sector Composition

Rank Sector Weight
1 Financials 20.5%
2 Industrials 19.89%
3 Technology 19.85%
4 Consumer Discretionary 10.32%
5 Healthcare 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKI
51
DELISTED
Black Knight, Inc. Common Stock
BKI
$105M 0.71%
1,625,753
+55,212
+4% +$3.64M
DIOD icon
52
Diodes
DIOD
$3.69B
$105M 0.71%
1,619,815
+415,886
+35% +$30.1M
STAG icon
53
STAG Industrial
STAG
$7.79B
$105M 0.7%
3,676,237
+99,018
+3% +$3.12M
SQM icon
54
Sociedad Química y Minera de Chile
SQM
$19.1B
$104M 0.7%
1,145,484
-206,714
-15% -$20.1M
SNPS icon
55
Synopsys
SNPS
$73.5B
$104M 0.7%
339,205
+22,393
+7% +$7.58M
SMG icon
56
ScottsMiracle-Gro
SMG
$4.25B
$103M 0.69%
2,418,904
+422,054
+21% +$30.3M
FRME icon
57
First Merchants
FRME
$2.74B
$100M 0.67%
2,589,309
-26,436
-1% -$1.05M
ARW icon
58
Arrow Electronics
ARW
$10.8B
$98.7M 0.66%
1,070,257
+89,368
+9% +$9.75M
EFSC icon
59
Enterprise Financial Services Corp
EFSC
$2.44B
$97.8M 0.66%
2,219,924
-19,748
-0.9% -$898K
ICLR icon
60
Icon
ICLR
$13.9B
$96.3M 0.65%
523,847
+56,193
+12% +$12.2M
BIO icon
61
Bio-Rad Laboratories Class A
BIO
$8.86B
$96.2M 0.65%
230,680
+6,464
+3% +$3.22M
AKAM icon
62
Akamai
AKAM
$16.3B
$95.5M 0.64%
1,189,133
+38,996
+3% +$3.55M
KEY icon
63
KeyCorp
KEY
$24.3B
$95.4M 0.64%
5,953,125
+351,133
+6% +$6.29M
ANSS
64
DELISTED
Ansys
ANSS
$94.5M 0.63%
426,152
+13,032
+3% +$3.33M
AROC icon
65
Archrock
AROC
$6.19B
$91.9M 0.62%
14,320,797
+299,020
+2% +$2.28M
CRL icon
66
Charles River Laboratories
CRL
$11.6B
$91.2M 0.61%
463,300
+288,052
+164% +$62.2M
PEB icon
67
Pebblebrook Hotel Trust
PEB
$2.2B
$89.9M 0.6%
6,194,589
+210,634
+4% +$3.79M
PGR icon
68
Progressive
PGR
$128B
$89.9M 0.6%
773,453
+12,662
+2% +$1.52M
ENS icon
69
EnerSys
ENS
$6.69B
$88.9M 0.6%
1,528,223
-14,001
-0.9% -$891K
IBN icon
70
ICICI Bank
IBN
$109B
$85.9M 0.58%
4,097,883
-93,662
-2% -$1.98M
QSR icon
71
Restaurant Brands International
QSR
$26B
$85.8M 0.58%
1,612,529
+9,354
+0.6% +$528K
AIR icon
72
AAR Corp
AIR
$5.62B
$85M 0.57%
2,372,828
-24,119
-1% -$1.03M
CHKP icon
73
Check Point Software Technologies
CHKP
$14.1B
$84.4M 0.57%
753,497
+5,062
+0.7% +$612K
HII icon
74
Huntington Ingalls Industries
HII
$11.8B
$84.3M 0.57%
380,543
+36,903
+11% +$8.28M
BIDU icon
75
Baidu
BIDU
$35.7B
$83.1M 0.56%
707,177
+3,727
+0.5% +$509K

Similar funds

EARNEST Partners's Q3 2022 Portfolio in Review

As of Q3 2022, EARNEST Partners held 1,195 positions worth $14.9B, down 0.84% from $15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

EARNEST Partners deployed $602M of net new capital in Q3 2022, opening 6 new positions and adding to 170 existing holdings. Its largest new stake was CTS Corp: 1,744,320 shares worth $72.7M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Meridian Bioscience Inc, an estimated $115M trimmed.

  • EARNEST Partners's largest Q3 2022 buy was CTS Corp: 1,744,320 shares worth $72.7M.
  • EARNEST Partners added most to United Community Banks in Q3 2022, an estimated $98.2M increase.
  • EARNEST Partners's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $115M.
  • EARNEST Partners fully exited Emergent Biosolutions in Q3 2022, selling an estimated $57.3M.
  • EARNEST Partners's ten largest holdings make up 17% of its $14.9B portfolio in Q3 2022.
  • EARNEST Partners opened 6 new positions and closed 18 in Q3 2022.
  • EARNEST Partners's portfolio value fell 0.84% quarter-over-quarter to $14.9B.

Based on EARNEST Partners's 13F filing for Q3 2022, filed 14 Nov 2022.